BoogarLists
Directory
Alpha
Angels
Services
US Listing
Clean Tech
Asian Pacific
Europe Listing
Mid-Market/LBO
Bio Life Sciences
Australia Listing
Canada Listing
Israel Listing
Universities
Networks


Bio Life Sciences


Print  

« 1-A B C-D E-G H-L M N-O P Q-R S T-U V-Z »

« Take  Third »

-Third-

Third Rock Ventures
Offices: Boston, Massachusetts
At Third Rock Ventures, their passion is the creation of meaningful life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. They work collaboratively with entrepreneurs to focus on creating value from technologies that have the potential for delivering multiple product opportunities. Founded in 2007, Third Rock Ventures has $378 million under management for exclusive investment in life-sciences, primarily in biotechnology, biopharmaceutical, and medical device companies.
Thomas McNerney & Partners
Offices: Stamford, Connecticut; Minneapolis, Minnesota & San Francisco, California
Thomas, McNerney & Partners is a health care private equity firm with $216 million under management that is focused on investing in life science and medical technology companies. The firm is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as other areas utilizing medical technology innovation. Companies developing therapeutic products for life threatening or costly, chronic conditions are of particular interest.
Three Arch Partners
Offices: Portola Valley, California
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fifty important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Trevi Health Ventures
Offices: New York, New York & London, England
Trevi Health Ventures is a healthcare investment firm with over $100 million under management. The investment team combines experienced investment professionals and senior-level executives/entrepreneurs with proven track records. Trevi provides development and growth capital for private healthcare companies with emphasis on medical devices, biopharmaceuticals and healthcare services.
Triathlon Medical Ventures
Offices: Cincinnati, Ohio; Indianapolis, Indiana; St Louis, Missouri & Louisville, Kentucky
Triathlon Medical Ventures invests exclusively in the life sciences. They provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs. Triathlon's team has been investing in life science business opportunities for more than fifteen years. And they are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.
Tullis Dickerson
Offices: Greenwich, Connecticut; Birmingham, Alabama; Ann Arbor, Michigan & Albuquerque, New Mexico
Tullis-Dickerson & Co. is a health care-focused private equity group, providing venture capital to small and mid-sized companies. The firm provides seed through late stage capital to creative, committed management teams leading growth companies. Through its established national and regional presence, Tullis-Dickerson has provided leadership, guidance and capital to a broad group of successful businesses, which have in some cases surpassed the billion-dollar revenue level and operate on a global basis.
Twilight Venture Partners
Offices: Indianapolis, Indiana
Twilight Venture Partners is a life sciences venture capital firm founded in September 2002. Collectively, their partners have more than 150 years of life science industry experience and have worked together for more than 25 years. Over that time, they created billions of dollars in value for their investors while bringing vital products to market that improved clinical outcomes and saved patient lives and maintaining the highest standards of integrity.